U.S. flag

An official website of the United States government

NM_004380.3(CREBBP):c.6250C>T (p.Gln2084Ter) AND Rubinstein-Taybi syndrome due to CREBBP mutations

Germline classification:
Likely pathogenic (2 submissions)
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001265550.2

Allele description [Variation Report for NM_004380.3(CREBBP):c.6250C>T (p.Gln2084Ter)]

NM_004380.3(CREBBP):c.6250C>T (p.Gln2084Ter)

Gene:
CREBBP:CREB binding protein [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
16p13.3
Genomic location:
Preferred name:
NM_004380.3(CREBBP):c.6250C>T (p.Gln2084Ter)
HGVS:
  • NC_000016.10:g.3728797G>A
  • NG_009873.2:g.156917C>T
  • NM_001079846.1:c.6136C>T
  • NM_004380.3:c.6250C>TMANE SELECT
  • NP_001073315.1:p.Gln2046Ter
  • NP_004371.2:p.Gln2084Ter
  • LRG_1426t1:c.6250C>T
  • LRG_1426:g.156917C>T
  • LRG_1426p1:p.Gln2084Ter
  • NC_000016.9:g.3778798G>A
  • NG_009873.1:g.156324C>T
  • NM_004380.2:c.6250C>T
Protein change:
Q2046*
Links:
dbSNP: rs2051825168
NCBI 1000 Genomes Browser:
rs2051825168
Molecular consequence:
  • NM_001079846.1:c.6136C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_004380.3:c.6250C>T - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Rubinstein-Taybi syndrome due to CREBBP mutations
Synonyms:
Rubinstein syndrome; Broad thumbs and great toes, characteristic facies, and mental retardation; RUBINSTEIN-TAYBI SYNDROME 1, INCOMPLETE; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0008393; MedGen: C4551859; Orphanet: 783; OMIM: 180849

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001443702Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenicgermlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV0040137923billion
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenicunknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedunknownyes1not providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego, SCV001443702.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This nonsense mutation is found in the last exon of CREBBP and it is therefore predicted to escape nonsense-mediated mRNA decay (NMD). However, the last exon of this gene is large and nonsense/frameshift mutations located downstream of this variant have been reported as disease-causing variants in the Human Gene Mutation Database (PMID: 15706485, 18792986, 25388907). This variant has not been previously reported or functionally characterized in the literature to our knowledge. It is absent from the gnomAD population database and thus is presumed to be rare. The c.6250C>T (p.Gln2084Ter) variant is predicted by multiple in silico tools to have a deleterious effect on protein function. Analysis of the parental samples was negative for the variant, indicating this variant likely occurred as a de novo event. Based on the available evidence, the c.6250C>T (p.Gln2084Ter) variant is classified as Pathogenic

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From 3billion, SCV004013792.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (1)

Description

The variant is not observed in the gnomAD v2.1.1 dataset. The variant is predicted to result in a loss or disruption of normal protein function through protein truncation. The predicted truncated protein may be shortened by more than 10%. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported to be associated with CREBBP related disorder (ClinVar ID: VCV000984922). Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyesnot providednot providednot provided1not providednot providednot provided

Last Updated: Jul 22, 2023